Gambro BCT's Vista(TM) Software Receives FDA Market Clearance

Gambro BCT's Vista(TM) Software Receives FDA Market Clearance Stockholm, Sweden, July 25, 2002The introduction of Vista allows Gambro BCT to enter the blood collection software market. Vista is designed to help blood centers manage business processes and information associated with automated blood collection. Key Vista features include component blood loss tracking, interfaces with collection devices, automated donor management, and business decision support. "Today, our customers face increasing regulatory and information management challenges," states Michael Seely, Vice President of Gambro BCT US and AMPAC (Americas and Pacific) Sales. "Maintaining multiple systems and the need for manual record keeping increases a center's potential for errors and adds to their work load." Vista addresses these challenges through unique software, open architecture, and partnerships with key information technology providers that will automate and integrate blood center processes and information. "The combination of Vista software and Gambro BCT's Trima® Automated Blood Collection Systems will allow our customers to dramatically increase business productivity, while improving their level of donor care and safety," Seely concludes. Vista and Trima's combined productivity will provide centers with time and money savings, increased product yields, and opportunities to better utilize donors, staff, and equipment. "Vista represents a cornerstone of our blood bank technology strategy and a tremendous contribution to our customers," states David Perez, President, Gambro BCT, "Gambro BCT customers expect and trust us to provide the highest quality products and services for helping them manage their operations; we at Gambro are committed to meeting those objectives with innovative products such as Vista." Gambro BCT, headquartered in Lakewood, Colorado, is a world leader in blood bank technologies, automated blood collection, pathogen reduction techniques, and value added blood and cell based therapeutic services. For further information please contact: David Perez, President, Gambro BCT, tel +1-303-232-6800 Janette Jennische, Vice President, Corporate Communications, tel. +46-8- 613 65 99, +46-70-212 50 53 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/07/25/20020725BIT00560/wkr0001.doc http://www.waymaker.net/bitonline/2002/07/25/20020725BIT00560/wkr0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.